Design
Review
Authors
Loading...
May support VLDL receptor as therapeutic target in metabolic syndrome; leaves open clinical translation pending targeted trials.
Key points are not available for this paper at this time.
Takahashi et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: